3Jaffe ES,Harris NL,Diebold J,et al.World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues.A progress report[J].AmJ ClinPathol,1999,111 (1 Suppl 1):S8-12.
4Cheung MM,Chan J K,Lau WH,et al.Primary non-Hodgkin's lymphoma of the nose and nasopharynx:clinical features,tumor immunophenotype,and treatment outcome in 113 patients[J].J Clin Oncol,1998,16 (1):70-77.
5Peh SC,Quen QW.Nasal and nasal type natural killer (NK)/T-cell lymphoma:immunophenotype and Epstein-Barr virus (EBV)association[J].Med J Malaysia,2003,58(2):196-204.
6Garcia-Cosio M,Santon A,Mendez MC,et al.Nasopharyngeal/nasal type T/NK lymphomas:analysis of 14 cases and review of the literature[J].Tumori,2003,89(3):278-284.
7Chan JK,Sin VC,Wong KF,et al.Nonnasal lymphoma expressing the natural killer cell marker CD56:a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm[J].Blood,1997,89(12):4501-4513.
8Ribrag V,Ell Hajj M,Janot F,et al.Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx[J].Leukemia,2001,15(7):1123-1126.
9Logsdon MD,Ha CS,Kavadi VS,et al.Lymphoma of the nasal cavity and paranasal sinuses:improved outcome and altered prognostic factors with combined modality therapy[J].Cancer,1997,80(3):477-488.
10Miyamoto T,Yoshino T,Takehisa T,et al.Cutaneous presentation of nasal/nasal type T/NK cell lymphoma:clinicopathological findings of four cases[J].Br J Dermatol,1998,139(3):481-487.
